A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus)
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Argenx BVBA
Start Date
March 16, 2021
End Date
March 31, 2025
Administered By
Dermatology
Awarded By
Argenx BVBA
Start Date
March 16, 2021
End Date
March 31, 2025